Skip to main content

Advertisement

SpringerLink
Log in

Simvastatin and Preparation of Polyunsaturated Phospholipids Produce Similar Changes in the Phospholipid Composition of High-Density Lipoproteins during Hypercholesterolemia

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

We studied the phospholipid composition of high-density lipoproteins in patients with coronary heart disease and hypercholesterolemia treated with simvastatin (Zocor, inhibitor of the key enzyme of cholesterol synthesis) and preparation of polyunsaturated phospholipids (lipostabil forte). Simvastatin produced a hypolipidemic effect and modulates the phospholipid composition of high-density lipoproteins (similarly to lipostabil forte). These changes contribute to functional activity of high-density lipoproteins in the reverse cholesterol transport.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. N. M. Akhmedzhanov, A. D. Denisenko, V. O. Konstantinov, et al., Klin. Farmakol. Ter., No. 1, 39–41 (1997).

  2. I. N. Ozerova, I. V. Paramonova, A. M. Olfer’ev, et al., Byull. Eksp. Biol. Med., 132, No.8, 178–180 (2001).

    Google Scholar 

  3. C. J. Fielding and P. J. Fielding, J. Lipid Res., 38, 1503–1521 (1997).

    CAS  PubMed  Google Scholar 

  4. N. Fournier, J. L. Paul, V. Atger, et al., Arterioscler. Thromb. Vasc. Biol., 17, 2685–2691 (1997).

    CAS  PubMed  Google Scholar 

  5. V. H. Hamilton, F. E. Racicot, H. Zowall, et al., JAMA, 273, No.13, 1032–1038 (1995).

    CAS  PubMed  Google Scholar 

  6. F. Kunz, C. Pechlaner, R. Erhart, et al., Arterioscler. Thromb., 14, 1146–1150 (1994).

    CAS  PubMed  Google Scholar 

  7. S. Lan Hsia, R. Duncan, A. H. Schob, et al., Atherosclerosis, 152, No.2, 469–473 (2000).

    CAS  PubMed  Google Scholar 

  8. Randomized Trial of Cholesterol Lowering in 4444 Patients with Coronary Heart Disease: the Scandinavian Simvastatin Survival Study (4S) // Lancet, 344, 1383–1389 (1994).

  9. The “Essential” Phospholipids as a Membrane Therapeutic, Ed. K.-J. Gundermann, Szczecin (1993).

  10. A. R. Tall, X. Jiang, Yi. Luo, et al., Arterioscler. Thromb. Vasc. Biol., 20, 1185–1188 (2000).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Metabolic Disorders, State Research Center of Preventive Medicine, Russian Ministry of Health, Moscow, Russia

    I. N. Ozerova, N. M. Akhmedzhanov, N. V. Perova & I. V. Paramonova

Authors
  1. I. N. Ozerova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. N. M. Akhmedzhanov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. N. V. Perova
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. I. V. Paramonova
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

__________

Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 139, No. 2, pp. 178–180, February, 2005

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ozerova, I.N., Akhmedzhanov, N.M., Perova, N.V. et al. Simvastatin and Preparation of Polyunsaturated Phospholipids Produce Similar Changes in the Phospholipid Composition of High-Density Lipoproteins during Hypercholesterolemia. Bull Exp Biol Med 139, 210–212 (2005). https://doi.org/10.1007/s10517-005-0250-1

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10517-005-0250-1

Key Words

Search

Navigation